diallyl disulfide has been researched along with Peritoneal Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
He, J; Huang, WG; Liao, QJ; Su, Q; Tan, H; Zhao, J | 1 |
1 other study(ies) available for diallyl disulfide and Peritoneal Neoplasms
Article | Year |
---|---|
Diallyl disulfide suppresses growth of HL-60 cell through increasing histone acetylation and p21WAF1 expression in vivo and in vitro.
Topics: Acetylation; Allyl Compounds; Animals; Antineoplastic Agents; Cell Cycle; Cell Differentiation; Cyclin-Dependent Kinase Inhibitor p21; Disulfides; Garlic; Histones; HL-60 Cells; Humans; Mice; Mice, SCID; Neoplasm Transplantation; Peritoneal Neoplasms; Random Allocation | 2006 |